Replies to post #69544 on $heff's $tation of $tocks & $olid DD

[$heff]

APPY..$1.33..Key data points changed. Venaxis now expects to complete enrollment now for the pivotal study by the end of 2013. They also expect to file for FDA clearance in Q1 2014. That is 4 months later than the complete enrollment at end of August with data release in Q4. Definitely a longer time frame when you are a biotech trader. That is why it is important to trade these nice pops and lock some profit on the way up.